| Product Code: ETC6047403 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Algeria Chronic Obstructive Pulmonary Disease (COPD) Drug Market Overview |
3.1 Algeria Country Macro Economic Indicators |
3.2 Algeria Chronic Obstructive Pulmonary Disease (COPD) Drug Market Revenues & Volume, 2021 & 2031F |
3.3 Algeria Chronic Obstructive Pulmonary Disease (COPD) Drug Market - Industry Life Cycle |
3.4 Algeria Chronic Obstructive Pulmonary Disease (COPD) Drug Market - Porter's Five Forces |
3.5 Algeria Chronic Obstructive Pulmonary Disease (COPD) Drug Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.6 Algeria Chronic Obstructive Pulmonary Disease (COPD) Drug Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 Algeria Chronic Obstructive Pulmonary Disease (COPD) Drug Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.8 Algeria Chronic Obstructive Pulmonary Disease (COPD) Drug Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.9 Algeria Chronic Obstructive Pulmonary Disease (COPD) Drug Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.10 Algeria Chronic Obstructive Pulmonary Disease (COPD) Drug Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Algeria Chronic Obstructive Pulmonary Disease (COPD) Drug Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of COPD in Algeria |
4.2.2 Growing awareness about COPD and its treatment options |
4.2.3 Government initiatives to improve healthcare infrastructure and access to COPD drugs |
4.3 Market Restraints |
4.3.1 High cost of COPD drugs leading to affordability issues for patients |
4.3.2 Limited healthcare budget allocation for COPD treatment |
4.3.3 Lack of skilled healthcare professionals specializing in COPD management |
5 Algeria Chronic Obstructive Pulmonary Disease (COPD) Drug Market Trends |
6 Algeria Chronic Obstructive Pulmonary Disease (COPD) Drug Market, By Types |
6.1 Algeria Chronic Obstructive Pulmonary Disease (COPD) Drug Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 Algeria Chronic Obstructive Pulmonary Disease (COPD) Drug Market Revenues & Volume, By Drug Type, 2021- 2031F |
6.1.3 Algeria Chronic Obstructive Pulmonary Disease (COPD) Drug Market Revenues & Volume, By Phosphodiestrase-4 Inhibitors, 2021- 2031F |
6.1.4 Algeria Chronic Obstructive Pulmonary Disease (COPD) Drug Market Revenues & Volume, By Long-Acting Bronchodilators, 2021- 2031F |
6.1.5 Algeria Chronic Obstructive Pulmonary Disease (COPD) Drug Market Revenues & Volume, By Short-Acting Bronchodilators, 2021- 2031F |
6.1.6 Algeria Chronic Obstructive Pulmonary Disease (COPD) Drug Market Revenues & Volume, By Methylxanthines, 2021- 2031F |
6.1.7 Algeria Chronic Obstructive Pulmonary Disease (COPD) Drug Market Revenues & Volume, By Corticosteroids, 2021- 2031F |
6.2 Algeria Chronic Obstructive Pulmonary Disease (COPD) Drug Market, By Product Type |
6.2.1 Overview and Analysis |
6.2.2 Algeria Chronic Obstructive Pulmonary Disease (COPD) Drug Market Revenues & Volume, By Inhalers, 2021- 2031F |
6.2.3 Algeria Chronic Obstructive Pulmonary Disease (COPD) Drug Market Revenues & Volume, By Nebulizers, 2021- 2031F |
6.3 Algeria Chronic Obstructive Pulmonary Disease (COPD) Drug Market, By Type |
6.3.1 Overview and Analysis |
6.3.2 Algeria Chronic Obstructive Pulmonary Disease (COPD) Drug Market Revenues & Volume, By Chronic Bronchitis, 2021- 2031F |
6.3.3 Algeria Chronic Obstructive Pulmonary Disease (COPD) Drug Market Revenues & Volume, By Emphysema, 2021- 2031F |
6.4 Algeria Chronic Obstructive Pulmonary Disease (COPD) Drug Market, By Diagnosis |
6.4.1 Overview and Analysis |
6.4.2 Algeria Chronic Obstructive Pulmonary Disease (COPD) Drug Market Revenues & Volume, By Pirometry, 2021- 2031F |
6.4.3 Algeria Chronic Obstructive Pulmonary Disease (COPD) Drug Market Revenues & Volume, By Diagnostic Tests, 2021- 2031F |
6.4.4 Algeria Chronic Obstructive Pulmonary Disease (COPD) Drug Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Algeria Chronic Obstructive Pulmonary Disease (COPD) Drug Market, By Treatment |
6.5.1 Overview and Analysis |
6.5.2 Algeria Chronic Obstructive Pulmonary Disease (COPD) Drug Market Revenues & Volume, By Oxygen Therapy, 2021- 2031F |
6.5.3 Algeria Chronic Obstructive Pulmonary Disease (COPD) Drug Market Revenues & Volume, By Lung Transplant, 2021- 2031F |
6.5.4 Algeria Chronic Obstructive Pulmonary Disease (COPD) Drug Market Revenues & Volume, By Drug Therapy, 2021- 2031F |
6.5.5 Algeria Chronic Obstructive Pulmonary Disease (COPD) Drug Market Revenues & Volume, By Vaccination, 2021- 2031F |
6.5.6 Algeria Chronic Obstructive Pulmonary Disease (COPD) Drug Market Revenues & Volume, By Surgery, 2021- 2031F |
6.5.7 Algeria Chronic Obstructive Pulmonary Disease (COPD) Drug Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Algeria Chronic Obstructive Pulmonary Disease (COPD) Drug Market, By End User |
6.6.1 Overview and Analysis |
6.6.2 Algeria Chronic Obstructive Pulmonary Disease (COPD) Drug Market Revenues & Volume, By Hospitals & Clinics, 2021- 2031F |
6.6.3 Algeria Chronic Obstructive Pulmonary Disease (COPD) Drug Market Revenues & Volume, By Home Care Settings, 2021- 2031F |
6.6.4 Algeria Chronic Obstructive Pulmonary Disease (COPD) Drug Market Revenues & Volume, By Others, 2021- 2031F |
7 Algeria Chronic Obstructive Pulmonary Disease (COPD) Drug Market Import-Export Trade Statistics |
7.1 Algeria Chronic Obstructive Pulmonary Disease (COPD) Drug Market Export to Major Countries |
7.2 Algeria Chronic Obstructive Pulmonary Disease (COPD) Drug Market Imports from Major Countries |
8 Algeria Chronic Obstructive Pulmonary Disease (COPD) Drug Market Key Performance Indicators |
8.1 Number of COPD diagnoses in Algeria |
8.2 Patient adherence to COPD treatment regimens |
8.3 Rate of hospital readmissions for COPD patients |
9 Algeria Chronic Obstructive Pulmonary Disease (COPD) Drug Market - Opportunity Assessment |
9.1 Algeria Chronic Obstructive Pulmonary Disease (COPD) Drug Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.2 Algeria Chronic Obstructive Pulmonary Disease (COPD) Drug Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.3 Algeria Chronic Obstructive Pulmonary Disease (COPD) Drug Market Opportunity Assessment, By Type, 2021 & 2031F |
9.4 Algeria Chronic Obstructive Pulmonary Disease (COPD) Drug Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.5 Algeria Chronic Obstructive Pulmonary Disease (COPD) Drug Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.6 Algeria Chronic Obstructive Pulmonary Disease (COPD) Drug Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Algeria Chronic Obstructive Pulmonary Disease (COPD) Drug Market - Competitive Landscape |
10.1 Algeria Chronic Obstructive Pulmonary Disease (COPD) Drug Market Revenue Share, By Companies, 2024 |
10.2 Algeria Chronic Obstructive Pulmonary Disease (COPD) Drug Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here